Assoziation von KRAS/STK11/KEAP1 Mutationen und Outcome in der POSEIDON Studie: Durvalumab+/− Tremelimumab+Chemotherapie beim metastasierten NSCLC (mNSCLC)

Details

Request a copyRequest a copy
Serval ID
serval:BIB_BEC283C28682
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Institution
UNIL/CHUV
Title
Assoziation von KRAS/STK11/KEAP1 Mutationen und Outcome in der POSEIDON Studie: Durvalumab+/− Tremelimumab+Chemotherapie beim metastasierten NSCLC (mNSCLC)
Title of the conference
63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.
Author(s)
Reinmuth N, Peters S, Cho B, Luft A, Alatorre-Alexander J, Geater S, Kim S, Ursol G, Hussein M, Lim F, Yang C, Araujo L, Saito H, Stewart R, Lai Z, Doake R, Krug L, Garon E, Mok T, Johnson M, Eberhardt W
ISSN
1438-8790
Publication state
Published
Issued date
03/2023
Language
english
OAI-PMH
oai:serval.unil.ch:BIB_BEC283C28682
DOI
10.1055/s-0043-1760880
Web of science
000992441800011
Create date
05/03/2024 17:13
Last modification date
06/03/2024 8:17
Usage data